Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ad.hIFN-β in Refractory Colorectal Carcinoma With Liver Metastases
NCT00107861Phase 2Completed
- Sponsor
- Biogen
- Start
- May 2005
- Countries
- 1
01
Overview
A Phase 2 trial of Ad.hIFN-β in colorectal carcinoma (CRC), sponsored by Biogen. Started May 2005; status: completed.
02
Drugs
Ad.hIFN-β
03
Conditions
colorectal carcinoma (CRC)
Beyond the preview
Go deeper on NCT00107861.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00107861.